• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冈比亚锥虫病动物宿主的流行病学研究。第二部分。人群的寄生虫学和免疫诊断检查。

Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part II. Parasitological and immunodiagnostic examination of the human population.

作者信息

Felgner P, Brinkmann U, Zillmann U, Mehlitz D, Abu-Ishira S

出版信息

Tropenmed Parasitol. 1981 Sep;32(3):134-40.

PMID:6285560
Abstract

The prevalence of the disease was determined in the population (n = 3402) of a highly endemic sleeping sickness area in the Ivory Coast and an area of recent low endemicity in southwestern Upper Volta by using parasitological techniques supplemented by the determination of trypanosome specific antibodies and serum macroglobulins (IgM). 62 cases of trypanosomiasis were diagnosed parasitologically in the sleeping sickness focus in the Ivory Coast. 30 Trypanozoon stocks were established for their behavioural and biochemical characterization. The percentage of specific antibody carriers. 26% and 10% obtained with the enzyme-linked immunosorbent assay (ELISA) in both areas, respectively, was compared to that obtained for raised IgM levels. False negative diagnosis resulted in 24% with the ELISA, 12% with the indirect immunofluorescent test (IFT) and 19% with the radial immunodiffusion (RID). Considering IFT and IgM levels together, the proportion of false negative results fell to 8%. Possible reasons for low sensitivities, especially of the ELISA are discussed.

摘要

通过寄生虫学技术并辅以锥虫特异性抗体和血清巨球蛋白(IgM)的测定,在象牙海岸一个昏睡病高度流行地区以及上沃尔特西南部一个近期低度流行地区的人群(n = 3402)中确定了该病的患病率。在象牙海岸的昏睡病疫源地,通过寄生虫学诊断出62例锥虫病病例。建立了30株锥虫菌株用于其行为和生化特性研究。将两个地区分别通过酶联免疫吸附测定(ELISA)获得的特异性抗体携带者百分比(分别为26%和10%)与IgM水平升高者的百分比进行了比较。ELISA的假阴性诊断率为24%,间接免疫荧光试验(IFT)为12%,放射免疫扩散法(RID)为19%。将IFT和IgM水平综合考虑,假阴性结果的比例降至8%。讨论了敏感性较低尤其是ELISA敏感性较低的可能原因。

相似文献

1
Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part II. Parasitological and immunodiagnostic examination of the human population.冈比亚锥虫病动物宿主的流行病学研究。第二部分。人群的寄生虫学和免疫诊断检查。
Tropenmed Parasitol. 1981 Sep;32(3):134-40.
2
Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part I. Review of literature and description of the study areas.关于冈比亚锥虫病动物宿主的流行病学研究。第一部分。文献综述及研究区域描述。
Tropenmed Parasitol. 1981 Sep;32(3):129-33.
3
[The epidemiology of human trypanosomiasis due to Trypanosoma gambiense in a focus of the Ivory Coast. I. The distribution of the disease in the population (author's transl)].[象牙海岸一个疫源地冈比亚锥虫所致人体锥虫病的流行病学。I. 疾病在人群中的分布(作者译)]
Tropenmed Parasitol. 1981 Sep;32(3):141-4.
4
Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum.
Tropenmed Parasitol. 1982 Jun;33(2):113-8.
5
[Ivory Coast uprising and returning Burkinabe immigrants: evaluation of the risk for reemergence of sleeping sickness in Burkina Faso].[科特迪瓦起义与布基纳法索移民返乡:布基纳法索昏睡病再度出现的风险评估]
Med Trop (Mars). 2010 Dec;70(5-6):490-6.
6
Evaluation of immunoassays for diagnosis and management of sleeping sickness in Liberia.利比里亚昏睡病诊断与管理免疫测定法的评估
Tropenmed Parasitol. 1984 Sep;35(3):137-40.
7
[Human African trypanosomiasis in mangrove epidemiologic area. Presentation, diagnosis and treatment in Guinea, 2005-2007].[红树林流行地区的人类非洲锥虫病。几内亚2005 - 2007年的临床表现、诊断与治疗]
Pathol Biol (Paris). 2010 Feb;58(1):110-6. doi: 10.1016/j.patbio.2009.07.033. Epub 2009 Oct 24.
8
[Human trypanosomiasis focus of Vavoua (Ivory Coast). A clinical, parasitological and sero-immunological survey (author's transl)].瓦武阿(科特迪瓦)人体锥虫病疫区。临床、寄生虫学及血清免疫学调查(作者译)
Med Trop (Mars). 1979 Sep-Oct;39(5):517-26.
9
An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.喀麦隆丰特姆昏睡病疫区锥虫病卡片凝集试验(CATT)试剂反应性评估
Afr J Med Med Sci. 1994 Mar;23(1):39-46.
10
Immunodiagnosis of sleeping sickness due to Trypanosoma brucei gambiense by detection of antiprocyclic antibodies and trypanosome antigens in patients' sera.通过检测患者血清中的抗循环抗体和锥虫抗原对布氏冈比亚锥虫所致昏睡病进行免疫诊断。
Acta Trop. 1989 Jul;46(4):257-66. doi: 10.1016/0001-706x(89)90026-0.

引用本文的文献

1
Enantiospecific antitrypanosomal in vitro activity of eflornithine.依发林碱体外抗锥虫的对映体选择性活性。
PLoS Negl Trop Dis. 2021 Jul 12;15(7):e0009583. doi: 10.1371/journal.pntd.0009583. eCollection 2021 Jul.
2
In Vitro Drug Efficacy Testing Against Trypanosoma brucei.抗布氏锥虫的体外药物疗效测试。
Methods Mol Biol. 2020;2116:781-789. doi: 10.1007/978-1-0716-0294-2_46.
3
Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.水甘油通道蛋白缺失的锥虫表现出甘油转运缺陷和对呼吸抑制剂的敏感性。
PLoS Pathog. 2017 Mar 30;13(3):e1006307. doi: 10.1371/journal.ppat.1006307. eCollection 2017 Mar.
4
A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.一种可杀死布氏冈比亚锥虫的灵长类载脂蛋白L1变体。
PLoS Negl Trop Dis. 2016 Aug 5;10(8):e0004903. doi: 10.1371/journal.pntd.0004903. eCollection 2016 Aug.
5
A new approach to chemotherapy: drug-induced differentiation kills African trypanosomes.化疗新方法:药物诱导分化杀死非洲锥虫。
Sci Rep. 2016 Mar 2;6:22451. doi: 10.1038/srep22451.
6
A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.一场共同进化的军备竞赛:锥虫塑造人类基因组,人类塑造锥虫基因组。
Parasitology. 2015 Feb;142 Suppl 1(Suppl 1):S108-19. doi: 10.1017/S0031182014000602.
7
In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.用于治疗第二阶段非洲昏睡病的新型双脒28DAP010的体外和体内评估。
Antimicrob Agents Chemother. 2014 Aug;58(8):4452-63. doi: 10.1128/AAC.02309-13. Epub 2014 May 27.
8
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.无鞭毛体利什曼原虫野毒株的水通道蛋白 2 突变与对喷他脒和米替福新的敏感性降低相关。
PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2475. doi: 10.1371/journal.pntd.0002475. eCollection 2013.
9
Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.DB829 的药代动力学、冈比亚锥虫疗效和药物作用时间,一种用于治疗第二期人类非洲锥虫病的临床前候选药物。
Antimicrob Agents Chemother. 2013 Nov;57(11):5330-43. doi: 10.1128/AAC.00398-13. Epub 2013 Aug 19.
10
Human and animal Trypanosomes in Côte d'Ivoire form a single breeding population.科特迪瓦的人体和动物锥虫形成了单一的繁殖群体。
PLoS One. 2013 Jul 2;8(7):e67852. doi: 10.1371/journal.pone.0067852. Print 2013.